Your shopping cart is currently empty

CDD-2211 is an STK33 inhibitor with a Kd value of 0.018 nM and an IC50 value of 5 nM. It exhibits weak inhibition of off-target kinases, with IC50 values of 115 nM, 48 nM, 187 nM, and 78 nM for CLK1, CLK2, CLK4, and RET, respectively. CDD-2211 may be used in contraception research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CDD-2211 is an STK33 inhibitor with a Kd value of 0.018 nM and an IC50 value of 5 nM. It exhibits weak inhibition of off-target kinases, with IC50 values of 115 nM, 48 nM, 187 nM, and 78 nM for CLK1, CLK2, CLK4, and RET, respectively. CDD-2211 may be used in contraception research. |
| Molecular Weight | 434.54 |
| Formula | C28H26N4O |
| Cas No. | 3086535-51-2 |
| Smiles | C(#CC1=C(C=CC=C1)C2=CC=CC=C2)C=3C=4C(NN3)=CC=C(C(=O)N5C[C@H](N(C)C)CC5)C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.